BioAnalytics is a biotechnology company developing the next generation of tools for protein analysis. Using a unique chemical synthesis technique, BioAnalytics modifies existing antibodies to amplify their binding strength by over 100 fold. This process results in drastic improvements in sensitivity and specificity, two of the most important factors in biological test fidelity. BioAnalytics uses this technique along with a proprietary method for simplified protein detection to develop tests with faster turnaround times, decreased variability, improved specificity, higher sensitivity, and increased capacity for multiplexing. BioAnalytics is currently focused on commercializing tests for use in academic research and pharmaceutical development, but ultimately plans on applying their technology to point-of-care medical diagnostics.